Barriers and enablers to medication adherence to cardiovascular medicines: a qualitative evidence synthesis to guide cardiovascular prevention
American Journal of Preventive Cardiology · 2026-09 · 101844
DOI: 10.1016/j.ajpc.2026.101844 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Preventive Cardiology, 2026-09. Verfasst von Caroline Trin und 12 weiteren Autor:innen. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council.
Abstract (Originalsprache)
Background
Cardiovascular disease (CVD) remains a leading contributor to the global burden of disease. Although pharmacological therapy is central to CVD prevention and management, medication adherence remains suboptimal, limiting treatment effectiveness and long-term cardiovascular outcomes.
Methods
This qualitative evidence synthesis followed the Joanna Briggs Institute Manual for Evidence Synthesis. Searches were conducted in September 2024 and updated in January 2025 across Medline, CINAHL, Embase, and PsycINFO for studies published between February 2004 and January 2025. Framework analysis was guided by the World Health Organization’s conceptual framework for medication adherence. A purposive maximum variation sampling approach was applied across low-income countries, underserved communities, rural populations, and primary and secondary CVD prevention settings.
Results
Of 145 eligible studies, 27 were synthesised. Medication adherence was influenced by interacting patient-related, therapy-related, healthcare system, and socioeconomic factors. Key barriers included fear of side effects, negative medication beliefs, poor patient-provider communication, financial hardship, fragmented care, and limited healthcare access. Important enablers included trust-based healthcare relationships, understanding treatment purpose, simplified medication regimens, and strong social support. Participants in secondary prevention settings demonstrated heightened risk perception, whereas those in primary prevention often viewed CVD as asymptomatic and were less aware of cardiovascular risk. Rural and low-income populations experienced greater structural and financial inequities, while underserved communities described limited resources and lack of personalised care contributing to non-adherence.
Conclusion
Structural inequities, healthcare relationships, and patient beliefs interact to shape medication adherence behaviours. Tailored strategies addressing communication, perceptual barriers, and population-specific needs may improve adherence outcomes and inform future intervention design for CVD prevention.
Förderung
- National Health and Medical Research Council
Zitieren
APA
Trin, C., Green, S., Causing, J., Chodapuneedi, S., Gasevic, D., Ademi, Z., Zomer, E., Zoungas, S., Eliakundu, A. L., Berkovic, D., Cao, K., Dalli, L., & Talic, S. (2026). Barriers and enablers to medication adherence to cardiovascular medicines: a qualitative evidence synthesis to guide cardiovascular prevention. American Journal of Preventive Cardiology, 101844. https://doi.org/10.1016/j.ajpc.2026.101844
Vancouver
Trin C, Green S, Causing J, Chodapuneedi S, Gasevic D, Ademi Z, et al. Barriers and enablers to medication adherence to cardiovascular medicines: a qualitative evidence synthesis to guide cardiovascular prevention. American Journal of Preventive Cardiology. 2026:101844. doi:10.1016/j.ajpc.2026.101844
BibTeX
@article{Trin2026,
author = {Trin, Caroline and Green, Sally and Causing, Justine and Chodapuneedi, Sri and Gasevic, Danijela and Ademi, Zanfina and Zomer, Ella and Zoungas, Sophia and Eliakundu, Amminadab L and Berkovic, Danielle and Cao, Khanh and Dalli, Lachlan and Talic, Stella},
title = {Barriers and enablers to medication adherence to cardiovascular medicines: a qualitative evidence synthesis to guide cardiovascular prevention},
journal = {American Journal of Preventive Cardiology},
year = {2026},
pages = {101844},
doi = {10.1016/j.ajpc.2026.101844}
}
EUVIMED